Rankings
▼
Calendar
▼
INBS Q4 2017 Earnings Report — Intelligent Bio Solutions Inc. Revenue & Financial Results | Market Cap Arena
Intelligent Bio Solutions Inc.
INBS
Q4 2017 Earnings
Reported June 30, 2017
Quarter Comparison
Revenue
Operating Income
Gross Margin
Net Margin
EPS (Diluted)
Metric
Q4 2017
Q3 2017
Q4 2016
QoQ Change
YoY Change
Revenue
-$62
—
—
—
—
Op. Income
-$125.6K
—
—
—
—
Gross Margin
100.0%
—
—
—
—
Net Margin
325914.5%
—
—
—
—
EPS (Diluted)
$-58.80
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
-$62
Cost of Revenue
$0
GROSS PROFIT
-$62
R&D Expenses
$0
Selling & Marketing
$34.2K
General & Administrative
$91.3K
SG&A Expenses
$125.5K
Other Expenses
$0
Operating Expenses
$125.5K
Cost & Expenses
$125.5K
OPERATING INCOME
-$125.6K
Interest Income
$0
Interest Expense
$76.5K
Other Income/Expenses
-$76.5K
INCOME BEFORE TAX
-$202.1K
Income Tax Expense
$0
Net Income from Continuing Ops
-$202.1K
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$202.1K
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$202.1K
D&A
$125.6K
EBIT
-$125.6K
EBITDA
$0
EPS
-$59
EPS Diluted
-$59
marketcaparena.com
← Q1 2018
INBS Overview